Fortress Biotech Cash Flow Statement (2013-2025) | FBIO

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025
Operating Activities
Net Income (Quarter)	-29.79M	-42.71M	-50.19M	-62.33M	-47.13M	-50.78M	-53.06M	-57.40M	-57.83M	-49.49M	-10.68M	-28.76M	-35.83M	-27.15M	-26.69M	-26.30M	-21.83M	-35.85M	8.83M	-5.51M
Depreciation and Depletion (Quarter)	0.60M	0.60M	0.70M	0.73M	0.74M	0.80M	0.80M	0.81M	0.80M	0.80M	0.40M	0.38M	0.38M	0.40M	0.10M	0.14M	0.13M	0.10M	0.10M	0.09M
Share-based Compensation (Quarter)	3.77M	4.35M	4.33M	7.04M	5.56M	5.08M	6.84M	5.51M	4.73M	4.22M	4.38M	3.70M	4.86M	5.00M	6.57M	16.19M	6.29M	16.79M	3.20M	2.46M
Cash from Discontinued Operations (Quarter)
Gains from Sales and Divestitures (Quarter)	0.24M	0.20M	0.49M	0.71M	0.14M	0.14M	0.55M	1.76M	0.06M	0.14M	0.04M	0.18M	607.00	0.05M	0.10M	0.02M	0.01M	0.01M	0.74M	0.37M
Gains from Investment Securities (Quarter)		0.03M	0.04M	-0.66M	0.00M	0.00M	0.00M	0.26M	0.00M	0.00M	166.00	-0.43M		0.54M	0.54M	-0.14M	0.54M	0.54M	0.54M
Asset Writedowns and Impairment (Quarter)	0.07M	-0.13M	-0.01M	0.12M	-0.08M	0.08M	0.01M	-0.01M	0.13M	3.14M		-2.71M	0.01M	2.65M		1.04M	0.20M	-0.44M	0.25M	-0.21M
Non-cash Items (Quarter)								0.10M	0.60M	0.60M	0.40M		400.00M	0.60M	0.60M	0.40M
Cash from Operations (Quarter)	-21.69M	-34.46M	-21.70M	-38.70M	-46.86M	-41.42M	-43.27M	-47.84M	-43.22M	-33.29M	-16.78M	-34.94M	-25.39M	-21.84M	-20.06M	-12.91M	-19.56M	-27.56M	-6.11M	-12.54M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	0.58M	0.20M	0.79M	2.29M	0.44M	1.00M	1.00M	0.54M	0.52M	1.10M	0.80M	1.47M	0.81M	0.81M	0.81M	0.98M	1.06M	1.06M	1.06M	2.79M
Amortization of Deferred Charges (Quarter)	0.22M	0.22M	0.17M	0.17M	0.20M	0.21M	0.20M	0.15M	0.09M	0.09M	0.18M
Depreciation & Amortization (CF) (Quarter)	0.60M	0.60M	0.70M	0.73M	0.74M	0.80M	0.80M	0.81M	0.80M	0.80M	0.40M	0.38M	0.38M	0.40M	0.10M	0.14M	0.13M	0.10M	0.10M	0.09M
Change in Working Capital
Change in Receivables (Quarter)	0.16M	2.05M	5.54M	-8.51M	8.00M	-2.48M	-0.08M	-0.05M	-0.47M	-10.43M	-8.83M	7.18M	-5.42M	0.81M	0.88M	-0.75M	7.99M	-2.82M	2.42M	11.76M
Change in Inventory (Quarter)	0.89M	12.02M	-2.70M	-1.75M	0.23M	-0.08M	-0.82M	-1.07M	-0.88M	-1.11M	-1.14M	-0.82M	0.37M	-0.89M	2.10M	2.64M	-1.94M	0.36M	-1.03M	-2.19M
Change in Account Payables (Quarter)
Change in Accured Expenses (Quarter)	-0.05M	5.88M	-5.70M	-0.05M	2.19M	-2.28M	-0.05M	8.49M	-0.05M	-0.05M	-16.92M	16.23M	-0.05M	-2.08M	-4.99M	0.73M	0.59M	-8.41M	6.31M	-0.17M
Change in Taxes (Quarter)				0.34M	0.00M	-0.00M	0.01M	0.36M		0.00M	0.08M	0.04M		-0.04M	0.04M	0.08M	0.02M	0.03M	0.02M	-0.65M
Investing Activities
Change in Net Loans (Quarter)
Capital Expenditures (Quarter)	0.55M	1.60M	0.46M	-1.34M	0.04M	1.61M	0.98M	0.09M	0.02M	0.02M	0.00M	0.03M		1.40M	-1.40M
Sales of Property, Plant and Equipment (Quarter)																	1.17M
Change in Intangibles (Quarter)								-20.00M								15.00M
Acquisitions (Quarter)					-20.00M				-5.00M
Divestments (Quarter)																		25.10M	2.87M
Change in Acquisitions & Divestments (Quarter)
Cash from Investing Activities (Quarter)	-0.46M	-4.84M	-7.54M	53.35M	-21.34M	-0.31M	-0.89M	-0.39M	-5.00M	-2.04M	5.00M	-0.06M				-15.00M	1.17M	6.09M	2.87M
Financing Activities
Other financing activities (Quarter)	0.00M	-0.00M	0.00M	0.28M	0.00M		-0.01M	0.18M	0.00M	-0.01M							-0.00M	0.00M	-0.00M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)				7.00M				5.00M	28.00M		-28.00M	28.00M			33.72M	-33.72M
Long-Term Debt Repayments (Quarter)	1.80M	1.00M	2.50M	5.15M	2.00M		-1.19M	-0.81M	27.95M	3.00M	-29.95M	29.95M			0.62M	0.62M	0.62M
Short-Term Debt issuances (Quarter)
Short-Term Debt repayments (Quarter)							5.00M				-0.00M	14.62M			-0.05M	5.00M
Change in Capital Stock
Shares Issued (Quarter)		0.14M	2.61M	-2.47M	4.23M	1.30M	0.22M	0.30M	0.45M	0.72M	0.55M	-0.01M	0.89M	-0.86M	3.36M	0.34M	36.00M	-34.99M	1.27M	0.37M
Shares Repurchased (Quarter)
Preferred Shares Issued (Quarter)	12.54M	0.26M	4.17M						0.65M
Preferred Shares Repurchased (Quarter)
Dividend Payments
Dividends Paid - Common (Quarter)	0.19M	0.19M	0.19M	0.19M	2.01M	0.19M	0.19M	0.19M	0.19M	0.18M	0.18M	-5.29M	2.01M	-1.66M	3.66M	-3.32M		0.33M	0.17M	-0.50M
Misc.
Cash from Financing Activities (Quarter)	78.69M	24.39M	6.97M	38.94M	49.96M	2.99M	3.75M	18.62M	22.19M	-30.38M	-2.69M	43.62M	27.86M	14.27M	2.71M	25.81M	52.14M	4.52M	15.07M	5.71M
Change in Cash (Quarter)	56.55M	-14.90M	-22.27M	53.60M	-18.23M	-38.74M	-40.42M	-29.62M	-26.03M	-65.71M	-14.46M	8.62M	2.47M	-7.57M	-17.35M	-2.10M	33.74M	-16.95M	11.83M	-6.84M
Beginning Cash Balance (Quarter)
Free Cash Flow (Quarter)	-22.23M	-36.06M	-22.16M	-37.36M	-46.90M	-43.03M	-44.25M	-47.94M	-43.24M	-33.31M	-16.78M	-34.96M	-25.39M	-23.23M	-18.66M	-12.91M	-19.56M	-27.56M	-6.11M	-12.54M
Net Cash Flow (Quarter)	56.55M	-14.90M	-22.27M	53.60M	-18.23M	-38.74M	-40.42M	-29.62M	-26.03M	-65.71M	-14.46M	8.62M	2.47M	-7.57M	-17.35M	-2.10M	33.74M	-16.95M	11.83M	-6.84M

Research Tools

Fortress Biotech Cash Flow Statement (2013-2025) | FBIO

Create an account

Sign In

Reset Password